|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/00 | |||
| A61P 31/18 |
| (11) | Number of the document | 3183270 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15832985.4 |
| Date of filing the European patent application | 2015-08-20 | |
| (97) | Date of publication of the European application | 2017-06-28 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/046160 |
| Date | 2015-08-20 |
| (87) | Number | WO 2016/029049 |
| Date | 2016-02-25 |
| (30) | Number | Date | Country code |
| 201462039620 P | 2014-08-20 | US | |
| 201562192941 P | 2015-07-15 | US |
| (72) |
SCHOOLEY, Robert T., US
POURHASSAN, Nader Z., US
|
| (73) |
CytoDyn Inc.,
1111 Main Street Suite 660, Vancouver, WA 98660,
US
|
| (54) | HIV ANTIBODY THERAPY AS TREATMENT SUBSTITUTE |
| HIV ANTIBODY THERAPY AS TREATMENT SUBSTITUTE |